Full automation of total metabolic tumor volume from FDG-PET/CT in DLBCL for baseline risk assessments

Full automation of total metabolic tumor volume from FDG-PET/CT in DLBCL for baseline risk assessments

Abstract Background Current radiological assessments of 18fluorodeoxyglucose-positron emission tomography (FDG-PET) imaging data in diffuse large B-cell lymphoma (DLBCL) can be time consuming, do not yield real-time information regarding disease burden and organ involvement, and hinder the use of FD...

Full description

Bibliographic Details
Main Authors: S. Jemaa, J. N. Paulson, M. Hutchings, L. Kostakoglu, J. Trotman, S. Tracy, A. de Crespigny, R. A. D. Carano, T. C. El-Galaly, T. G. Nielsen, T. Bengtsson
Format: Article
Language:English
Published: BMC 2022-08-01
Series:Cancer Imaging
Subjects:
DLBCL
FDG-PET
Imaging
AI
Online Access:https://doi.org/10.1186/s40644-022-00476-0

Internet

https://doi.org/10.1186/s40644-022-00476-0

Similar Items